International Clinical Trial: A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821684) titled 'A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AbbVie

Condition: Non-Squamous Non-Small Cell Lung Cancer

Intervention: Drug: Telisotuzumab Adizutecan Drug: Docetaxel

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 6,...